FORA · As filed with the SEC
Forian income statement, by quarter
The statement as Forian presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS · USD, except per-share amounts
| USD, except per-share amounts | Q1 2026 3 months ended Mar 31, 2026 | Q4 2025† 3 months ended Dec 31, 2025 | Q3 2025 3 months ended Sep 30, 2025 | Q2 2025 3 months ended Jun 30, 2025 | Q1 2025 3 months ended Mar 31, 2025 | Q4 2024† 3 months ended Dec 31, 2024 |
|---|---|---|---|---|---|---|
| Revenue | 6,851,095 | 7,962,480† | 7,762,183 | 7,476,140 | 7,056,116 | 5,812,472† |
| Costs and Expenses: | ||||||
| Cost of revenues | 4,844,102 | 4,043,488† | 3,753,561 | 3,228,169 | 3,131,622 | 2,420,968† |
| Research and development | 961,458 | 958,582† | 676,172 | 675,731 | 606,237 | 455,693† |
| Sales and marketing | 1,482,486 | 1,694,440† | 1,461,348 | 1,495,710 | 1,382,727 | 1,304,506† |
| General and administrative | 2,447,074 | 2,040,777† | 2,118,273 | 1,971,959 | 3,279,094 | 3,165,510† |
| Litigation settlements and related expenses | — | 0† | 0 | 0 | 0 | (482,715)† |
| Depreciation and amortization | 51,884 | 52,136† | 52,135 | 52,350 | 51,101 | 39,984† |
| Strategic review and transaction related expenses | 551,824 | 1,118,835† | 170,579 | 6,145 | — | 356,830† |
| Total costs and expenses | 10,338,828 | 9,908,258† | 8,232,068 | 7,430,064 | 8,450,781 | 7,260,776† |
| Operating Loss | (3,487,733) | (1,945,778)† | (469,885) | 46,076 | (1,394,665) | (1,448,304)† |
| Other Income (Expense): | ||||||
| Change in fair value of warrant liability | — | 0† | 0 | 0 | 0 | 0† |
| Interest and investment income | 155,543 | 247,715† | 336,002 | 347,968 | 328,848 | 470,449† |
| Gain on sale of investment | — | 0† | 0 | 0 | 0 | 0† |
| Interest expense | 0 | 0† | (35,984) | (53,689) | (52,678) | (121,249)† |
| Gain on debt redemption | — | 0† | 0 | 0 | 0 | 145,703† |
| Total other income, net | 155,543 | 247,715† | 300,018 | 294,279 | 276,170 | 1,699,733† |
| Net loss before income taxes | (3,332,190) | (1,698,063)† | (169,867) | 340,355 | (1,118,495) | 251,429† |
| Income tax expense | (29,920) | (123,690)† | 18,647 | (115,562) | (7,367) | (51,718)† |
| Net loss | — | — | (151,220) | 224,793 | (1,125,862) | 199,711† |
| Net loss | (3,362,110) | — | — | — | — | — |
| Basic net loss per common share (in Dollars per share) | (0.11) | — | 0.00 | 0.01 | (0.04) | — |
| Diluted net loss per common share (in Dollars per share) | (0.11) | — | 0.00 | 0.01 | (0.04) | — |
| Weighted-average shares outstanding - basic (in Shares) | 31,152,930 | — | 31,082,725 | 31,202,312 | 31,123,075 | — |
| Weighted-average shares outstanding - diluted (in Shares) | 31,152,930 | — | 31,082,725 | 31,293,644 | 31,123,075 | — |
† Derived: worked out from the filings, not stated in them. A fourth quarter is the 10-K year less the nine months in the third-quarter 10-Q; a quarter of cash flows is year to date less the prior year to date.
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.